cortavance
virbac s.a. - hydrocortisone aceponate - corticosteroids, dermatological preparations - dogs - for symptomatic treatment of inflammatory and pruritic dermatoses in dogs.for alleviation of clinical signs associated with atopic dermatitis in dogs.
cortavance solution
virbac ah, inc. - hydrocortisone aceponate - solution - 0.584mg - hydrocortisone aceponate 0.584mg - dogs
cortavance cutaneous spray solution for dogs
virbac (australia) pty ltd - hydrocortisone aceponate - topical solution/suspension - hydrocortisone aceponate steroid-glucocorticoid active 0.584 mg/ml - endocrine system - dog | bitch | castrate | puppy - flea allergic dermatitis | pruritis | skin conditions | allergic skin disorder | bacterial skin conditions | dermatoses | eczema | fungal skin conditions | nonspecific skin conditions | skin treatment
cortavance
virbac new zealand limited - hydrocortisone aceponate - hydrocortisone aceponate 0.58 g/litre - anti-inflammatory
cortavance 0.584 mg/ml cutaneous spray solution for dogs
virbac - hydrocortisone aceponate - cutaneous spray, solution - anti inflammatory corticosteroid - dogs
cortavance 584mcg/ml cutaneous spray solution
virbac philippines, inc; distributor: virbac philippines, inc - hydrocortisone aceponate (vet.) - cutaneous spray solution - 584mcg/ml
cortavance
virbac rs.a (pty) ltd - hydrocortisone aceponate - solution - 0.5842mg
cortavance spray
virbac rsa (pty) ltd - spray - see ingredients - each 1,0 ml spray contains hydrocortisone aceponate 0,584 mg - c 13.3.1 topical corticosteroids with or without anti-infective agents
hydrocortisone aceponate ecuphar (previously cortacare)
ecuphar - hydrocortisone aceponate - corticosteroids, dermatological preparations - dogs - for symptomatic treatment of inflammatory and pruritic dermatoses in dogs.for alleviation of clinical signs associated with atopic dermatitis in dogs.
fosavance 70 mg5600 i.u. tablets
merck sharp & dohme israel ltd - alendronic acid as alendronate sodium trihydrate; colecalciferol - tablets - colecalciferol 140 mcg; alendronic acid as alendronate sodium trihydrate 70 mg - colecalciferol - colecalciferol - fosavance is indicated for : - treatment of osteoporosis in postmenopausal women: fosavance increases bone mass and reduces the incidence of fractures, including those of the hip and spine (vertebral compression fractures). - treatment to increase bone mass in men with osteoporosis.